Objective: To estimate the prevalence of chronic conditions among children admitted to U.S. pediatric intensive care units and to assess whether patients with complex chronic conditions experience pediatric intensive care unit mortality and prolonged length of stay risk beyond that predicted by commonly used severity-ofillness risk-adjustment models.
C hildren with complex chronic conditions (CCCs) have considerable, ongoing care needs (1) (2) (3) , more so than children with noncomplex chronic conditions (NCCCs) (4) . Children with CCC accounted for 10% to 17% of hospitalized children in 2006 (5, 6) , and this prevalence has increased since the 1990s (6, 7) . These children may be more highly represented among patients admitted to pediatric intensive care units (PICUs), as indicated by single-site studies (8) (9) (10) (11) . However, the prevalence of CCC among a broader population of PICU patients is unknown.
Although the prevalence of CCC among hospitalized children is increasing, the two most commonly used risk-adjustment models for severity-of-illness-Pediatric Index of Mortality (PIM) 2 (12) and Pediatric Risk of Mortality (PRISM) III (13)-include few chronic conditions in their models. These risk-adjustment models are utilized for predicting mortality and comparing performance across PICUs (14) . Given the disproportionate hospital mortality seen among children with CCC compared to children without chronic conditions (7, 15, 16) , it is necessary to assess the impact of CCC on mortality beyond that predicted by these risk models. In addition, knowing whether CCC confers additional risk may be necessary for improving future risk-adjustment models.
Therefore, we sought to estimate the prevalence and variation of prevalence of CCCs among children admitted to U.S. PICUs, using a multi-institutional dataset. We subsequently sought to determine if having any CCC and which CCC subcategories were associated with increased risk of PICU mortality and prolonged length of stay (LOS) above that predicted by commonly used risk-adjustment models. Finally, we sought to determine if inclusion of CCC into risk-adjustment models improved prediction of PICU mortality at the unit level, as measured by standardized mortality ratios (SMRs).
MATERIALS AND METHODS

Data Source and Cohort Selection.
We performed a retrospective cohort study of consecutive patients 21 yrs of age admitted in 2008 to 70 U.S. PICUs in 32 states that participated in the Virtual Pediatric Intensive Care Unit Systems (VPS, LLC, Los Angeles, CA). VPS is a collaboration between the Children's Hospital Association, National Outcomes Center of Children's Hospital and Health System in Wisconsin, and Children's Hospital Los Angeles. It contains encounter-level information entered by VPS-trained persons at the individual sites. Annual certification of data definitions, routine interrater reliability testing, and automated and manual data cleaning queries ensure data quality. Upon approval of our research proposal, data were provided by VPS. No endorsement or editorial restriction of the interpretation of these data or opinions of the authors have been implied or stated. The University of California, San Francisco Committee on Human Subjects approved the study.
Patients were excluded if their sites did not submit data for variables selected for the final regression models. To look for clinically relevant selection bias in our sample, included and excluded patients were compared across characteristics, and substantial differences were described.
Chronic Conditions. The original definition for CCC was developed by Feudtner et al (1) : "Any medical condition that can be reasonably expected to last at least 12 months (unless death intervenes) and to involve either several different organ systems or 1 organ system severely enough to require specialty pediatric care and probably some period of hospitalization in a tertiary care center." This definition was accompanied by a now widely-used list of International Classification of Diseases, Ninth revision, codes of diagnoses that they determined met this definition (17) . However, in reviewing this diagnoses list, we found that there were diagnoses that were missing (e.g., diabetes mellitus and primary pulmonary hypertension), some that were not complex (e.g., benign adenomas and fibromas) or not chronic (e.g., premature atrial contractions and ventricular tachycardia). For these reasons, all VPS diagnoses were reviewed by a group of blinded experts, which included researchers of children with CCC, pediatric intensivists, a pediatric cardiac intensivist, a pediatric oncologist/hematologist, and a rheumatologist to determine which met the original definition by Feudtner et al. The resulting modified list was used in our analyses, and a comparison of this list to the list by Feudtner et al is provided in online Appendix (Supplemental Digital Content 1, http://links.lww.com/CCM/ A439). In order to ensure capture of chronic conditions, when a patient had an acute condition or status code that necessarily implied an underlying chronic condition (e.g., tracheostomy complication), the patient was counted as having a chronic condition. The remaining diagnoses that could be expected to last 12 months but not meet the additional CCC criteria were designated as NCCC. To be consistent with Feudtner's CCC subcategories, chronic conditions were further grouped into nine organ systems (cardiovascular, respiratory, neuromuscular, congenital/genetic abnormalities, oncologic, metabolic/endocrinologic, renal, gastrointestinal, and hematologic/ immunologic). A tenth miscellaneous subcategory was created to incorporate rheumatologic, orthopedic, and psychiatric conditions. Study Design and Variables. Hierarchical mixed-effects logistic regression models for PICU mortality and prolonged PICU stay with random effects at the unit level were fitted using the VPS cohort to estimate the association between predictor and outcome variables.
The primary predictor was the presence of a chronic condition, stratified into three levels of complexity: CCC, NCCC, and no chronic condition. Other potential independent variables included PIM2 score for severity-of-illness at admission, age, gender, race, elective vs. nonelective admission, perioperative status, trauma status, and having a previous PICU admission. Operative and elective statuses were excluded from the models to avoid collinearity, as they are included in PIM2. Age was converted into an ordinal variable (0-3 months, 3-24 months, 2 yrs of age), as there are age-specific effects for different CCCs.
The primary outcome was death during PICU admission. A dichotomous variable was created for the secondary outcome, prolonged PICU LOS, in order to provide odds ratios (ORs). Prolonged LOS was defined as continuous care in a PICU for 95th percentile of the entire cohort's LOS (18) . LOS in days was calculated by subtracting the PICU admission date and time from the PICU discharge date and time.
Statistical Analysis. Patients were stratified by chronic condition status. Patients who had both a CCC and an NCCC were analyzed in the CCC group. When patients had multiple PICU admissions, these admissions were analyzed as unique encounters.
Variables were excluded if they were collinear (spearman  .75) with chronic condition status or severity-of-illness scores. Demographic and clinical characteristics were presented as proportions or medians and interquartile ranges. Comparisons of these characteristics between groups were performed using Pearson's chi-square test or the Kruskal-Wallis rank test, as appropriate.
Mixed-effects logistic regression models, clustered by PICU site, were used to estimate the association between predictors and outcomes as ORs with 95% confidence intervals (CIs). Predictors for the final regression models were included if their p value was .2 and were not collinear with other variables, although age and gender were retained as important clinical covariates. To assess model accuracy, C-statistic with 95% CI were calculated. The impact of adding CCC on accuracy was assessed using a chi-square test of equality. Hosmer-Lemeshow statistics were calculated to evaluate calibration. Clinically relevant interactions between chronic condition status and other variables were explored and described if significant.
In subanalyses, to evaluate the relevance of the number of chronic conditions, regressions were performed using a variable for the number of stratified chronic conditions (i.e., no chronic condition, one NCCC, ≥2 NCCC, one CCC, and ≥2 CCC). In addition, we used PRISM III scores in lieu of PIM2 in order to explore significant differences when this scoring system is used to risk-adjust severity-of-illness in a mortality model. A subanalysis using the original list by Feudtner et al of diagnoses was performed to determine the sensitivity of results to different CCC diagnoses lists.
Finally, to explore whether greater inclusion of CCC improves comparison of observed vs. expected PICU mortality across units, we estimated SMR and 95% CI for each unit using PIM2 alone and plus the CCC subcategories that significantly increased patients' risk of mortality. SMRs were calculated by dividing the mean observed unit mortality by the mean predicted mortality rate as determined by the risk-adjustment model. The difference between the SMRs determined by the two models was assessed using a Bland-Altman method of comparison (19) . Stata 11 (StataCorp LP, College Station, TX) was used for statistical analyses.
RESULTS
Chronic Conditions Stratification and
Prevalence. In 2008, 70 PICUs submitted data to the VPS database on 67,629 admissions. Sixteen (23%) units were excluded because they did not supply the requisite data for analysis ( Fig. 1) . Ultimately, 52,791 (78%) admissions from 54 (77%) units composed our study cohort.
There were no statistically significant differences between included and excluded patients in terms of gender, age, elective/ operative status, PIM2 score, LOS, or mortality. Compared to excluded patients, included patients were more likely to have been admitted electively (30% vs. 24%).
The demographic and clinical characteristics of the study patients, stratified by chronic condition status, are presented in Table 1 . Fifty-three percent of the cohort had a CCC; 18.5% had an NCCC. The prevalence of chronic conditions in patients admitted to PICUs varied considerably across the 54 units and subcategories (Table 2) .
PICU Mortality. PICU mortality was 2.7% (1,448 deaths). The majority of these deaths, 1,078 (74%), were children with CCC. Admission type (elective or not; perioperative status) and having a previous PICU admission were excluded due to collinearity with chronic condition status or PIM2. In multivariable analyses, race and reason for admission were not significant covariates. The adjusted ORs for the included predictor variables derived from the model for PICU mortality using chronic conditions stratified by complexity and organ subcategories are presented in Table 3 . Except for respiratory, gastrointestinal, and other conditions, CCC in every category had significant and greater odds of PICU mortality than their NCCC counterparts. The risk of PICU mortality varied considerably between different organ system categories. The C-statistics for our mortality model was 0.905 (95% CI 0.897-0.913), indicating excellent accuracy. C-statistics for models adjusting for PIM2 alone and plus gender, age, and trauma were 0.888 (95% CI 0.879-0.897). The test of equality between these models was p  .0001, indicating adding CCC resulted in a significant change in accuracy. The p value of the Hosmer-Lemeshow statistic was .07, indicating acceptable calibration.
When number of chronic conditions was analyzed, having one NCCC was associated with 66% lower odds of PICU mortality (OR 0.34; 95% CI 0.22-0.53, p.001) compared to children with no chronic condition, adjusting for age, gender, trauma, and severity-of-illness. Having ≥2 NCCC was not associated with PICU mortality (OR 0.9; 95% CI 0.39-2.1, p  .81) compared to children with no chronic condition. Increasing number of CCCs was associated with increasing odds of PICU mortality compared to having no chronic condition-the adjusted ORs for one CCC was 1.7 (95% CI 1.43-2) and 2.9 (95% CI 2.4-3.5) for ≥2 CCC.
In our subanalysis using PRISM III, 41,583 (61%) patients from 39 (56%) units were analyzed. The associations were not significantly different than the PIM model (Supplemental Table 1 [Supplemental Digital Content 2, http:// links.lww.com/CCM/A440), except for the magnitude for some CCC subcategories' ORs. Only gastrointestinal CCC was newly associated with PICU mortality.
In the subanalysis using the CCM list by Feudtner et al, 29,280 (55.5%) of admissions were identified as having a CCC. When the association of CCC subcategories to PICU mortality were compared using Feudtner's and our modified CCC lists, some significant differences were found (Supplemental Table 2 Supplemental Digital Content 2, http://links.lww.com/ CCM/A440). Specifically, using our list, cardiovascular and neuromuscular CCCs were associated with PICU mortality, and gastrointestinal CCC was not.
SMRs for the 54 units are presented in Figure 2 . There was little difference between SMRs adjusting for PIM2 score and those adjusting for PIM2 and statistically significant CCC (cardiovascular, neuromuscular, oncologic, metabolic/ endocrinologic, renal, and hematologic/ immunologic). On Bland-Altman analysis, the mean difference between SMRs was 0.001 (95% limit of agreement 20.06 to 0.06).
Length of Stay. For our secondary outcome of prolonged PICU LOS, the 95th percentile of physical LOS for the entire cohort was 15 days. Children with CCC had 77% of admissions with LOS 15 days.
The adjusted ORs for prolonged LOS derived from the regression model for prolonged LOS are presented in Table 3 . CCC in every organ category had greater odds of prolonged LOS than their NCCC counterparts, except those in the miscellaneous category. Among NCCC, only cardiovascular, neuromuscular, and gastrointestinal subcategories had increased odds of prolonged LOS, compared to having no chronic condition. The C-statistic for our LOS model was 0.81 (95% CI 0.8-0.82); the Hosmer-Lemeshow statistic p value was .26.
Having one NCCC was weakly associated with decreased odds of prolonged LOS (OR 0.81; 95% CI 0.66-0.99; p  .043), compared to having no chronic condition. Having ≥2 NCCC was not associated with prolonged LOS (p  .51). As with mortality, having more CCCs was associated with increasing odds of prolonged LOS. The adjusted ORs were 2.1 (95% CI 1.83-2.3) when a patient had one CCC compared to having no chronic condition and 4.6 (95% CI 4-5.2) for two or more CCC.
No statistically significant interactions were found between chronic condition status and other covariates in the models for either outcome.
DISCUSSION
Children with CCC are recognized as having ongoing, substantial healthcare needs (3). Although they are a relatively small proportion of children in the United States, they are highly represented among hospitalized children (5211, 15). Using a multi-institutional database, we demonstrated that children with chronic conditions comprised 70% of PICU admissions, and those with CCC comprised just over half. We demonstrated that patients with CCC have significant risk for PICU mortality and prolonged LOS beyond that predicted by commonly used severityof-illness models. Finally, we showed that the accuracy of predicting PICU mortality was significantly improved with the inclusion of CCC and other covariates, compared to adjusting for severity-of-illness alone, as indicated by a higher C-statistic and significant test of equality.
Earlier studies had not estimated the prevalence of children with CCC admitted to U.S. PICUs. Using 2004-2005 VPS data, Typpo and colleagues (20) found that 52% of children admitted to 28 PICUs had a chronic condition, but the distinction between CCC and NCCC was not examined. Using the 2006 Kids' Inpatient Database, Odetola et al (15) showed that 41% of children with respiratory failure or need for mechanical ventilation possessed a CCC, but they were not able to identify which children were in a PICU or assess critical illnesses other than respiratory failure. Our prevalence estimates are the first to be based on an U.S. multi-institutional cohort, to stratify chronic conditions into two levels of complexity, and to show that the prevalence of these conditions and their subcategories varied across PICUs.
Previous studies have addressed the association between chronic conditions and mortality. Feudtner et al (21) examined all pediatric hospitalizations in Pennsylvania over multiple years and estimated the association between hospital mortality and different CCC subcategories. However, they could not distinguish between PICU and non-PICU patients, and they used a proprietary, infrequently used severityof-illness risk-adjustment. Odetola et al (15) did not risk-adjust but only compared mortality of children with CCC to those without chronic conditions. Typpo et al (20) found an association between PICU mortality and having 3 chronic conditions. While they examined organ subcategories and controlled for acute organ dysfunction, they did not examine CCC nor incorporate a commonly used mortality risk-adjustment. In order to address these limitations, we: 1) focused exclusively on PICU patients in a large database; 2) used common and valid severityof-illness risk-adjustment systems; and 3) distinguished between chronic conditions by level of complexity and by organ system. We found that children with any CCC, except a respiratory condition, had greater odds of PICU mortality compared to children with no chronic condition after controlling for severity-of-illness. Importantly, the magnitude of risk varied across organ system subcategories (ranging from an OR of 1.2 for gastrointestinal [p  .11] to 2.9 [p.001] for hematologic/ immunologic). All patients with CCC had significantly greater odds of prolonged LOS. Finally, no NCCC subcategories were associated with greater risk of PICU mortality, but some were with prolonged LOS, compared to children with no chronic conditions. Cardiovascular NCCC was associated with statistically lower odds of PICU mortality, compared to no chronic conditions.
The independent association of CCC with PICU mortality demonstrates that many CCC confer a significant risk to patients above that predicted by PIM and PRISM. Developed in 2003 and 1996, respectively, PIM2 and PRISM III incorporate few chronic conditions. PIM2 adjusts for seven high-risk diagnoses, including neurodegenerative disorders, certain immunodeficiencies, certain cardiovascular conditions, leukemia, and lymphoma (12) . PRISM III adjusts for chromosomal abnormalities and oncologic conditions (13) . However, when we estimated SMRs CCC, complex chronic condition; NCCC, noncomplex chronic condition; -, none or not applicable (no chronic condition group had no chronic conditions, and there were no NCCC hematologic/ immunologic diagnoses; they were all CCC). using PIM2 with and without statistically significant CCC subcategories, there was no substantive difference. The lack of difference may reflect our sample containing mostly tertiary PICUs, which care for similarly ill and complex patients. Therefore, institutions were similarly affected by the increased risk of mortality. Further research should address whether CCC rates are lower at community PICUs and whether inclusion of CCCs into risk-adjustment models has more impact when a more diverse sample of PICUs is evaluated.
Our study has a number of limitations. First, chronic conditions often have a range of severity, sequelae, and chronicity that is often not captured in diagnosis coding. Admittedly, this results in some subjectivity inherent in labeling CCC.
Nonetheless, identifying children with CCC through diagnoses codes has become an accepted approach. Originally, Feudtner and colleagues (1) constructed their list of CCC using clinical knowledge and a review of Washington State death certificates, and this list has become widely used (5-7, 15, 22) . However, we felt there were some weaknesses in this list that warranted modification. More specifically, Feudtner's list contains diagnoses that our expert panel assessed to be not complex (e.g., benign tumors and tics) or not chronic (e.g., ventricular fibrillation), assuming patients receive the standard of care. In addition, there were several CCC that were missing, including several hematologic and rheumatologic conditions, such as hemophilia and systemic lupus erythematosus. Thus, using their original definition of a CCC, we developed a modified list from the available VPS diagnoses (see online Appendix Supplemental Digital Content 1, http://links.lww.com/ CCM/A439) and used it in our analyses. Overall, there is considerable agreement between the two lists, with a few notable exceptions and important additions in our list.
Some of the differences in the measures of association in the PICU mortality model when Feudtner's CCC list and our modified list were used are readily explainable. Using the modified list, cardiovascular and neuromuscular CCCs were associated with increased PICU mortality. These differences are likely attributed to a more discriminatory cardiac diagnosis list that excluded several nonchronic and noncomplex conditions, and a more expansive list of neuromuscular diagnoses that met Feudtner's CCC definition. Also, using the modified list, gastrointestinal CCCs were not associated with PICU mortality. The only difference from Feudtner's in the modified list was the inclusion of status codes for ostomies and liver transplants, suggesting these conditions may not increase risk for PICU mortality beyond current severity-of-illness adjustments.
Other limitations include a lack of institutional characteristics in our models. Besides annual PICU volume, we were not provided with institutional characteristics. However, hierarchical regression models take into account that subjects receiving care at the same hospitals should not be treated as independent observations; rather they are "clustered within" institutions. In addition, our study is limited to PICU outcomes only, as VPS does not contain information on pre-or post-PICU care.
Thus, we could not analyze other important outcomes such as hospital mortality or LOS. Finally, besides the primary diagnosis, which by VPS definition is present at time of PICU admission, there was no designation of the timing of onset of chronic conditions in relation to admission. VPS diagnoses did not have a "present on admission" flag. So while all diagnoses pertinent to the patient's ICU course were required to be documented, it is conceivable that a small number of conditions first manifested during the admission. However, we were examining chronic conditions, which manifest over time and are unlikely to first appear during a PICU admission. CCC, complex chronic condition; NCCC, noncomplex chronic condition; -, none or not applicable (no chronic condition group had no chronic conditions, and there were no NCCC hematologic/ immunologic diagnoses; they were all CCC).
CONCLUSIONS
PICUs are a locus of care for children with CCC and are the likely place of many of their deaths. Knowing the prevalence of CCC in children admitted to PICUs and their contribution to PICU mortality and LOS aids in understanding the impact of CCC on these children and on acute care resources. Our findings add credence to assertions that greater efforts should be directed toward identifying and addressing the needs of children with CCC in order to minimize this impact. For PICU mortality benchmarking, additional inclusion of high-risk CCC subcategories into future risk-adjustment models would improve model accuracy compared to currently used models, but may lead to similar comparisons of observed vs. expected PICU mortality across units that care for children with CCC.
